255 related articles for article (PubMed ID: 37735428)
21. High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease.
Raphael JL; Mei M; Mueller BU; Giordano T
Pediatr Blood Cancer; 2012 Apr; 58(4):584-90. PubMed ID: 21584938
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes following bone marrow transplantation in patients with sickle cell disease: A cohort study of US Medicaid enrollees.
Mahesri M; Schneeweiss S; Globe D; Mutebi A; Bohn R; Achebe M; Levin R; Desai RJ
Eur J Haematol; 2021 Feb; 106(2):273-280. PubMed ID: 33155319
[TBL] [Abstract][Full Text] [Related]
23. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
Antwi-Boasiako C; Campbell AD
Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
[TBL] [Abstract][Full Text] [Related]
24. Time trends, sociodemographic and health factors associated with discharge and length of stay of hospitalised patients with sickle cell disease in Ghana: a retrospective analysis of national routine health database.
Narh CT; Der J; Ofosu A; Blettner M; Wollschlaeger D
BMJ Open; 2021 Oct; 11(10):e048407. PubMed ID: 34610933
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.
Pittman DD; Hines PC; Beidler D; Rybin D; Frelinger AL; Michelson AD; Liu K; Gao X; White J; Zaidi AU; Charnigo RJ; Callaghan MU
Blood; 2021 Apr; 137(15):2010-2020. PubMed ID: 33067606
[TBL] [Abstract][Full Text] [Related]
27. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic review.
Benenson I; Jadotte Y; Echevarria M
JBI Database System Rev Implement Rep; 2017 Mar; 15(3):765-808. PubMed ID: 28267033
[TBL] [Abstract][Full Text] [Related]
30. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis.
Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA
Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094
[TBL] [Abstract][Full Text] [Related]
31. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.
Vekeman F; Sasane M; Cheng WY; Ramanakumar AV; Fortier J; Qiu Y; Duh MS; Paley C; Adams-Graves P
J Med Econ; 2016; 19(3):292-303. PubMed ID: 26618853
[TBL] [Abstract][Full Text] [Related]
32. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
[TBL] [Abstract][Full Text] [Related]
33. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet JB; Colombatti R; de Montalembert M; Jain S; Jastaniah W; Nur E; Pita M; DeBonnett L; Ramscar N; Bailey T; Rajkovic-Hooley O; James J
Am J Hematol; 2021 Apr; 96(4):404-417. PubMed ID: 33264445
[TBL] [Abstract][Full Text] [Related]
34. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
35. The impact of Hydroxyurea on the rates of Vaso-occlusive crises in patients with sickle cell disease in Saudi Arabia: a single-center study.
Alkhalifah SA; Alanazi M; Almasaoud MA; Al-Malki HS; Al-Murdhi FM; Al-Hazzaa MS; Al-Mufarrij SM; Albabtain MA; Alshiakh AA; AlRuthia Y
BMC Emerg Med; 2022 Nov; 22(1):188. PubMed ID: 36447134
[TBL] [Abstract][Full Text] [Related]
36. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.
Lanzkron S; Carroll CP; Haywood C
Am J Hematol; 2010 Oct; 85(10):797-9. PubMed ID: 20730795
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study.
Ramsey SD; Bender MA; Li L; Johnson KM; Jiao B; Devine B; Basu A
PLoS One; 2022; 17(11):e0278137. PubMed ID: 36445914
[TBL] [Abstract][Full Text] [Related]
38. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
[No Abstract] [Full Text] [Related]
39. Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease.
Weaver SB; Rungkitwattanakul D; Singh D
J Pharm Pract; 2023 Feb; 36(1):139-148. PubMed ID: 34151636
[TBL] [Abstract][Full Text] [Related]
40. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
